Cryofocus Announces 2026 Interim Results: Loss Narrows 37.9% to RMB 16.9 Million, Gross Margin Improves to 68.5%Asian Corporate Newswire·Aug 28, 2026 at 02:04 PM06922+3.26%
Cryofocus Medtech FY26 H1 net loss narrows 37.9% to RMB 16.91 million; revenue falls to RMB 40.68 millionPUBT·Aug 28, 2026 at 10:01 AM06922+3.26%
Cryofocus Medtech schedules board meeting to review interim results, dividend recommendationPUBT·Aug 18, 2026 at 08:39 AM06922+3.26%
"Performance" CRYOFOCUS-B's annual loss narrowed to 38.169 million RMB, no dividend declaredAASTOCKS·Mar 30, 2026 at 01:56 AM06922+3.26%
CRYOFOCUS-B offers new shares at a discount of 17.79%, raising HKD 39.99 millionAASTOCKS·Jan 12, 2026 at 02:36 PM06922+3.26%
"Performance" CRYOFOCUS-B's mid-term loss narrowed to 23.82 million RMBAASTOCKS·Aug 10, 2025 at 10:11 AM06922+3.26%
CRYOFOCUS-B announced its interim results, with a loss attributable to the parent company's owners of 23.817 million yuan, a year-on-year narrowing of 54.35%Zhitong·Aug 8, 2025 at 12:42 PM06922+3.26%